Salomé Leibundgut-Landmann

Dr. Salomé Leibundgut-Landmann

Section of Immunology, Vetsuisse Faculty, University of Zurich, 8006 Zürich, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2007 in Nature Immunology
Verified
Journal Article
Closed access
Salomé Leibundgut-LandmannSalomé Leibundgut-Landmann
Salomé Leibundgut-Landmann
OGOlaf Groß
Olaf Groß
MRMatthew J Robinson
Matthew J Robinson
FOFabiola Osorio
Fabiola Osorio
ESEmma Slack
Emma Slack
CSCaetano Reis e Sousa
Caetano Reis e Sousa

21 October 2019 in European Journal of Immunology
Verified
Journal Article
Open access
ACAndrea Cossarizza
Andrea Cossarizza
HCHyun-Dong Chang
Hyun-Dong Chang
ARAndreas Radbruch
Andreas Radbruch
AAAndreas Acs
Andreas Acs
DADieter Adam
Dieter Adam
AZArturo Zychlinsky
Arturo Zychlinsky
These guidelines are a consensus work of a considerable number of members of the immunology and flow cytometry community. They provide the theory and key practical aspects of flow cytometry enabling immunologists to avoid the common errors that often undermine immunological data. Notably, there are comprehensive sections of all major immune cell types with helpful Tables detailing phenotypes in murine and human cells. The latest flow cytometry techniques and applications are also described, featuring examples of the data that can be generated and, importantly, how the data can be analysed. Furthermore, there are sections detailing tips, tricks and pitfalls to avoid, all written and peer‐reviewed by leading experts in the field, making this an essential research companion.

11 October 2017 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
ACAndrea Cossarizza
Andrea Cossarizza
HCHyun-Dong Chang
Hyun-Dong Chang
ARAndreas Radbruch
Andreas Radbruch
MAMübeccel Akdis
Mübeccel Akdis
IAImmanuel Andrä
Immanuel Andrä
JZJakob Zimmermann
Jakob Zimmermann
International audienceThe classical model of hematopoiesis established in the mouse postulates that lymphoid cells originate from a founder population of common lymphoid progenitors. Here, using a modeling approach in humanized mice, we showed that human lymphoid development stemmed from distinct populations of CD127(-) and CD127(+) early lymphoid progenitors (ELPs). Combining molecular analyses with in vitro and in vivo functional assays, we demonstrated that CD127(-) and CD127(+) ELPs emerged independently from lympho-mono-dendritic progenitors, responded differently to Notch1 signals, underwent divergent modes of lineage restriction, and displayed both common and specific differentiation potentials. Whereas CD127(-) ELPs comprised precursors of T cells, marginal zone B cells, and natural killer (NK) and innate lymphoid cells (ILCs), CD127(+) ELPs supported production of all NK cell, ILC, and B cell populations but lacked T potential. On the basis of these results, we propose a "two-family" model of human lymphoid development that differs from the prevailing model of hematopoiesis

1 October 2005 in Nature Reviews Immunology
Verified
Journal Article
Closed access
WRWalter Reith
Walter Reith
Salomé Leibundgut-LandmannSalomé Leibundgut-Landmann
Salomé Leibundgut-Landmann
JWJean-Marc Waldburger
Jean-Marc Waldburger

1 December 2006 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
MRMatthew J Robinson
Matthew J Robinson
David SanchoDavid Sancho
David Sancho
ESEmma Slack
Emma Slack
Salomé Leibundgut-LandmannSalomé Leibundgut-Landmann
Salomé Leibundgut-Landmann
CSCaetano Reis e Sousa
Caetano Reis e Sousa

15 January 2013 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
AGAndré Gladiator
André Gladiator
NWNicolette Wangler
Nicolette Wangler
KTKerstin Trautwein-Weidner
Kerstin Trautwein-Weidner
Salomé Leibundgut-LandmannSalomé Leibundgut-Landmann
Salomé Leibundgut-Landmann
IL-17–mediated immunity has emerged as a crucial host defense mechanism against fungal infections. Although Th cells are generally thought to act as the major source of IL-17 in response to Candida albicans, we show that fungal control is mediated by IL-17–secreting innate lymphoid cells (ILCs) and not by Th17 cells. By using a mouse model of oropharyngeal candidiasis we found that IL-17A and IL-17F, which are both crucial for pathogen clearance, are produced promptly upon infection in an IL-23–dependent manner, and that ILCs in the oral mucosa are the main source for these cytokines. Ab-mediated depletion of ILCs in RAG1-deficient mice or ILC deficiency in retinoic acid–related orphan receptor c−/− mice resulted in a complete failure to control the infection. Taken together, our data uncover the cellular basis for the IL-23/IL-17 axis, which acts right at the onset of infection when it is most needed for fungal control and host protection.